We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » Barr Receives Approval to Launch Generic Zonegran
Barr Receives Approval to Launch Generic Zonegran
January 10, 2006
Barr Pharmaceuticals has received final approval from the FDA for its abbreviated new drug application to manufacture and market zonisamide capsules in 25-, 50- and 100-mg dosage strengths.